Enhanced And Highly Specific Delivery Of Small Interfering RNA And Oligonucleotides As Therapeutics For Gene Silencing
Funder
National Health and Medical Research Council
Funding Amount
$311,860.00
Summary
This proposal aims to develop glyco-nanocarriers for the efficient and specific delivery of siRNA/oligonucleotides to treat liver diseases. Complex glycopolymer architectures developed here will protect desired genes from enzymatic degradation and will deliver the gene to the liver specifically for therapy, hence providing a solution towards nucleic acid therapy.
Titanium Implants With Dual Micro- And Nano-Scale Topography For Electrically Stimulated Osteogenic And Antibacterial Functions
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
The long-term success of titanium implants in high-risk patients (especially diabetics) is compromised and the current project aims to address this by developing nano-engineered therapeutic titanium implants. With appropriate multi-scale roughness, enhanced bioactivity, local antibiotic release and electrical stimulation to further enhance these features, the project aims at patient outcomes, while allowing easy integration into the current implant market.
Development Of An Antibody-targeted Drug/miRNA/peptide Delivery System For Effective Prevention Of Restenosis
Funder
National Health and Medical Research Council
Funding Amount
$319,064.00
Summary
The re-blocking of vessels after surgery occurs up to 50% of patients, and none of the preventive approaches are cost-effective and safe enough. This project aims to develop a nano-scaled therapeutics delivering combination therapies to effectively prevent the re-blockage after surgery. If successful, this research will present a whole new range of therapeutic agent that prevents the patient from developing clots after surgery, improving the productivity and health of patients with reduced cost.
NEW INSIGHTS IN TREATMENT AND DIAGNOSIS OF GLAUCOMA
Funder
National Health and Medical Research Council
Funding Amount
$419,180.00
Summary
Effective treatment of glaucoma and understanding the exact mechanism of cell death in glaucoma still remain challenging. Here I utilize a smart nanoparticle that could recognize sick cells followed by releasing drugs only to cells that are stressed and need the drug. High-resolution microscopy can map the detailed activity in retina after drug treatments. By doing so, we develop a novel way to deliver drugs to diagnose and treat glaucoma.
Ocular Implant For The Treatment Of Bacterial Endophthalmitis
Funder
National Health and Medical Research Council
Funding Amount
$483,446.00
Summary
We seek to develop an ocular implant for the treatment of bacterial endophthalmitis. The implant will be a small device that can be administered directly to the affected ocular cavity to release an antibiotic in a controlled manner to clear any infection. The implant will erode and leave no residue. It will be produced from a novel drug-polymer conjugate technology that allows polymer devices that comprise >50% drug to be made.
Advanced Polymer Systems For The Delivery Of Anti-Epileptic Drugs To The CNS
Funder
National Health and Medical Research Council
Funding Amount
$593,375.00
Summary
The use of organic conducting polymers as novel platforms for drug delivery is expected to provide significant improvements in our ability to treat and manage illnesses and trauma. A number of novel drug-loaded platforms with the introduction of a conducting polymer component to enable electrically stimulated release, generated physiologically (by onset of an epileptic seizure) or by a bio-corrosion process (stents) provides innovative drug release systems powered autonomously.